Denali Therapeutics DNLI
NASDAQ DNLI
$18.68 -0.25 (-1.32%)
At close: Oct 21, 2026 · 4:00 PM EDT

Denali Therapeutics (DNLI) EV to EBITDA (2020 - 2021)

Updated

Denali Therapeutics' (DNLI) EV to EBITDA stood at 150.18 in Q3 2021, up 8.7% from the prior quarter.

Analysis

Denali Therapeutics (DNLI) EV to EBITDA (2020 - 2021) Analysis & Trends

On a TTM basis, Denali Therapeutics' EV to EBITDA came in at 27.14 as of Sep 30, 2021; for FY2020, it was 121.07.

  • Per Business Quant, the preceding three quarters came in at 138.19 (Q2 2021), 91.75 (Q1 2021) and 121.07 (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Denali Therapeutics 3.51 Bn 96.04 Mn 3.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 150.18
Jun 30, 2021 138.19
Mar 31, 2021 91.75
Dec 31, 2020 121.07
API Access

Denali Therapeutics EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=DNLI&period=max&api_key=YOUR_API_KEY